Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers

Lung Cancer

Volumn 42, Issue 3, 2003, Pages 255-261

  Lin, Pinpin ^a   Chang, Han ^b   Ho, William L ^c   Wu, Meng Hsiang ^a   Su, Jang Ming ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Adenocarcinoma; Aryl hydrocarbon receptor; Cytochrome P4501B1; Non small cell lung cancer

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1B1;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUSCLE CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SMOOTH MUSCLE; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

EID: 0344120180     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00359-3     Document Type: Article

References (26)

1. Osann K.E. Epidemiology of lung cancer. Curr. Opin. Pulm. Med. 4:1998;198-204.
2. Murray G.I., Melvin W.T., Greenlee W.F., Burke M.D. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol. 41:2001;297-316.
3. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56:1996;2979-2984.
4. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J Natl Cancer Inst Monogr 2000;75-93.
5. Hatanaka N., Yamazaki H., Oda Y., Guengerich F.P., Nakajima M., Yokoi T. Metabolic activation of carcinogenic 1-nitropyrene by human cytochrome P4501B1 in Salmonella typhimurium strain expressing an O-acetyltransferase in SOS/umu assay. Mutat. Res. 497:2001;223-233.
6. Liehr J.G., Fang W.F., Sirbasku D.A., Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24:1986;353-356.
7. Murray G.I., Taylor M.C., McFadyen M.C., McKay J.A., Greenlee W.F., Burke M.D., Melvin W.T. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res. 57:1997;3026-3031.
8. Spivack S.D., Hurteau G.J., Reilly A.A., Aldous K.M., Ding X., Kaminsky L.S. CYP1B1 expression in human lung. Drug Metab. Dispos. 29:2001;916-922.
9. McFadyen M.C., McLeod H.L., Jackson F.C., Melvin W.T., Doehmer J., Murray G.I. Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance. Biochem. Pharmacol. 62:2001;207-212.
10. Hong W.K. The current status of docetaxel in solid tumors: an M.D. Anderson Cancer Center Review. Oncology (Huntington). 16:2002;9-15.
11. Department of Health tEY. 1997 Republic of China: General Health Statistics. Taipei, ROC; 1998. p. 82-9.
12. Lin P., Chang H., Tsai W.-T., Wu M.-H., Liao Y.-S., Chen J.-T., Su J.-M. Overexpression of aryl hydrocarbon receptor in human lung carcinomas. Toxicol. Pathol. 31:2003;22-30.
13. Kress S., Greenlee W.F. Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res. 57:1997;1264-1269.
14. Shehin S.E., Stephenson R.O., Greenlee W.F. Transcriptional regulation of the human CYP1B1 gene: evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression. J. Biol. Chem. 275:2000;6770-6776.
15. Gebremichael A., Tullis K., Denison M.S., Cheek J.M., Pinkerton K.E. Ah-receptor-dependent modulation of gene expression by aged and diluted sidestream cigarette smoke. Toxicol. Appl. Pharmacol. 141:1996;76-83.
16. Gazdar A.F., Minna J.D. Cigarettes, sex, and lung adenocarcinoma. J. Natl. Cancer Inst. 89:1997;1563-1565.
17. Travis W, Colby T, Corrin Y, Shimosato Y, Brambilla E, editors. Histological typing of lung and pleural tumors, third ed. New York: Springer; 1999. p. 1-72.
18. Sobin L, Wittekind C, editors. TNM classification of malignant tumors, fifth ed. New York: Wiley; 1997. p. 93-100.
19. Chang K.W., Lee H., Wang H.J., Chen S.Y., Lin P. Differential response to benzo[a]pyrene in human lung adenocarcinoma cell lines: the absence of aryl hydrocarbon receptor activation. Life Sci. 65:1999;1339-1349.
20. Song J., Clagett-Dame M., Peterson R.E., Hahn M.E., Westler W.M., Sicinski R.R., DeLuca H.F. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc. Natl. Acad. Sci. U.S.A. 99:2002;14694-14699.
21. Mollerup S., Ovrebo S., Haugen A. Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int. J. Cancer. 92:2001;18-25.
22. Anttila S., Hietanen E., Vainio H., Camus A.M., Gelboin H.V., Park S.S., Heikkila L., Karjalainen A., Bartsch H. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P4501A in lung cancer patients. Int. J. Cancer. 47:1991;681-685.
23. Saarikoski S.T., Husgafvel-Pursiainen K., Hirvonen A., Vainio H., Gonzalez F.J., Anttila S. Localization of CYP1A1 mRNA in human lung by in situ hybridization: comparison with immunohistochemical findings. Int. J. Cancer. 77:1998;33-39.
24. Li D., Walcott F.L., Chang P., Zhang W., Zhu J., Petrulis E., Singletary S.E., Sahin A.A., Bondy M.L. Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer. Cancer Res. 62:2002;4566-4570.
25. Kristensen V.N., Kure E.H., Erikstein B., Harada N., Borresen-Dale A. Genetic susceptibility and environmental estrogen-like compounds. Mutat. Res. 482:2001;77-82.
26. Hanna I.H., Dawling S., Roodi N., Guengerich F.P., Parl F.F. Cytochrome P4501B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 60:2000;3440-3444.